HDACs/EZH2-IN-1
HDACs/EZH2-IN-1 (Compound 22a) is a HDACs/EZH2 inhibitor (EZH2 Y641N inhibition rate at 50 nM: 98%), with selective inhibition against HDAC1 and HDAC6 (IC50: 0.23 μM and 0.07 μM, respectively). HDACs/EZH2-IN-1 exerts a antiproliferative effect on diffuse large B-cell lymphoma cells harboring an EZH2 mutation and on various acute myeloid leukemia cells. HDACs/EZH2-IN-1 has the ability to induce cell differentiation and Apoptosis.
For research use only. We do not sell to patients.
- Formula: C29H36BrN7O4
- Molecular Weight:626.54
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Histone Methyltransferase Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
HDAC1 0.23 μM (IC50) |
HDAC6 0.07 μM (IC50) |
HDAC4 >10 μM (IC50) |
HDAC11 >10 μM (IC50) |
EZH2 WT 0.84 nM (IC50) |
EZH2 Y641N 1.36 nM (IC50) |
In Vitro
HDACs/EZH2-IN-1 (5 μM, 48-120 h) displays strong antiproliferative activities against SU-DHL-6 cells, which is a DLBCL cell line harboring EZH2 Y641N mutation, with IC50 of 1.04 μM (48 h) and 0.17 μM (120 h)[1].
HDACs/EZH2-IN-1 (0.1-100 μM 48 h) inhibits the growth of AML cells, with IC50 of 1.39 μM (MV4-11), 2.45 μM (U937), and 1.32 μM (OCI-AML3)[1].
HDACs/EZH2-IN-1 (4 μM, 6 h) increases the intracellular levels of the HDAC1/2/3 substrate acetylhistone H3 (AC-HH3) and the HDAC6 substrate acetyl-α-tubulin (AC-α-tubulin) [1].
HDACs/EZH2-IN-1 (2 μM, 48 h) induces differentiation of MOLM13 cells, with increasing expression of two myeloid maturation markers CD11b and CD14[1].
HDACs/EZH2-IN-1 (2-4 μM, 48 h) induces apoptosis of MOLM13 cells dose-dependently[1].
HDACs/EZH2-IN-1 (1-2 μM) synergizes with anti-AML compounds (Cytarabine (HY-13605), Daunorubicin (HY-13062A), Gilteritinib (HY-12432)) against cancer in MOLM13 cells[1].
HDACs/EZH2-IN-1 shows good metabolic stability in human and rat plasma, with T1/2 of >180 and 138 min, respectively[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:SU-DHL-6, MOLM-13, OCI-AML2, MV4-11, U937 and OCI-AML3
-
Concentration:0.1, 1, 5, 10, 100 μM
-
Incubation Time:48, 120 h
-
Result:Displayed strong antiproliferative activities against SU-DHL-6 cells (5 μM, 48 h and 120 h).
Inhibited the growth of cell lines, with IC50 of 1.39 μM (MV4-11), 2.45 μM (U937), and 1.32 μM (OCI-AML3) (1, 10, 100 μM, 48 h).
-
Cell Line:MOLM13 cells
-
Concentration:4 μM
-
Incubation Time:6 h
-
Result:Increased the intracellular levels of the HDAC1/2/3 substrate acetylhistone H3 (AC-HH3) and the HDAC6 substrate acetyl-α-tubulin (AC-α-tubulin).
Led to a significant reduction in the levels of trimethylation at H3K27.
Chemical Information
-
Molecular Weight 626.54
-
Formula C29H36BrN7O4
-
SMILES
BrC1=CC(N(CC2CCN(CC2)C3=NC=C(C=N3)C(NO)=O)CC)=C(C(C(NCC4=C(C=C(NC4=O)C)C)=O)=C1)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
iPSC cell differentiation
Induced pluripotent stem cells (iPSCs) are a type of cell that has similar properties to embryonic stem cells through somatic cell reprogramming.
-
Genotoxicity/Mutagenicity Study
The bacterial reverse mutation assay detects point mutations that restore amino-acid prototrophy in auxotrophic Salmonella typhimurium or Escherichia coli tester strains; after exposure to a test article, mutagenic activity is read out as an increased number of revertant colonies on minimal agar compared with the vehicle control. The assay uses tester strains with different mutation targets so that base-substitution and frameshift mutagens can be detected, and testing is performed with and without exogenous mammalian metabolic activation because some chemicals require biotransformation to become mutagenic.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)